Story by Jeremy Todd | 1ST Medical Recruiting Battalion | 01.18.2019
Cooper University Hospital has a long history of working with the US Army and now has become the flagship for the U.S. Army's elite Forward Resuscitation Surgical Team (FRST)....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
The Joint Science and Technology Office (JSTO) Science Review (JSR) fosters collaboration, cooperation and innovation by allowing program managers and senior leadership to understand the latest warfighter-driven technologies in development....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
DNA-based nucleic acid vaccines have the potential to become a universal platform solution to viral threat agents. The U.S. Department of Defense is currently developing DNA vaccines to protect against a variety of viral threats including alphaviruses, filoviruses and hantaviruses....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
When Ebola virus disease (EVD) reared its head in May in the Congo, the world was armed with the rVSV-ZEBOV vaccine thanks to interagency collaboration efforts by the Defense Threat Reduction Agency’s Chemical and Biological Technologies Department....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 08.21.2018
Used in many attacks such as the 1995 Tokyo subway incident, multiple Syrian chemical strikes and several assassinations, horrifying nerve agent assaults are becoming more common for both civilians and warfighters. Although medical countermeasures exist to sustain life after organophosphate (OP) nerve agent exposure, the risk of brain damage, behavioral and neurological disorders due to......
